GlyProVac competitorsClear all
AC Immune's top competitors include Prosetta and Aprogen.
 AC Immune AC Immune is a biopharmaceutical company developing therapeutics against Alzheimer´s disease and other conformational diseases. |  Aprogen Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies. | ||
Founding Date | Founding Date 2003 | Founding Date N/A | Founding Date 2000 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Lausanne, CH HQ | Locations San Francisco, US HQ | Locations HQ |
Employees | Employees 125 | Employees 284% increase | Employees 693% increase |
Employee Rating | Employee Rating 3.5 | Employee Rating 3 | Employee Rating 3 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 2m (about 15 years ago) | Latest funding round $ 16.7m (over 2 years ago) |
Total funding raised | Total funding raised $ 117.4m | Total funding raised $ 2m | Total funding raised $ 16.7m |
For sources of this data, please see the company profile
View company profiles
Prosetta
HQ
San Francisco, US
Employees
28↑ 4% increase
Prosetta Corporation operates as a biopharmaceutical company in the United States.
View companyAprogen
HQ
Employees
69↑ 3% increase
Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies.
View company